BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
4.500
+0.100 (2.27%)
Feb 21, 2025, 4:00 PM EST - Market closed
BioAge Labs Employees
BioAge Labs had 56 employees as of December 31, 2023.
Employees
56
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,266,750
Market Cap
161.32M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
BIOA News
- 17 hours ago - BIOA SECURITIES NEWS: BioAge has been Sued for Securities Violations - Investors are Alerted to Contact BFA Law by March 10 Legal Deadline - Accesswire
- 18 hours ago - BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit – Hagens Berman - GlobeNewsWire
- 1 day ago - BioAge Labs to Participate in TD Cowen's 45th Annual Health Care Conference - GlobeNewsWire
- 1 day ago - BioAge Labs Stock Alert - Investors of BioAge Encouraged to Contact Kehoe Law Firm, P.C. - BIOA - Accesswire
- 2 days ago - DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - GlobeNewsWire
- 3 days ago - BIOA STOCK NEWS: Robbins LLP Reminds BioAge Labs, Inc. Investors of the Pending Lead Plaintiff Deadline – March 10, 2025 - GlobeNewsWire
- 3 days ago - BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit - PRNewsWire
- 3 days ago - BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit - Hagens Berman - Accesswire